F. Dequiedt et al., LACK OF MUTATION IN THE WAF1 CIP1 GENE DURING BOVINE LEUKEMIA VIRUS-INDUCED LEUKEMOGENESIS/, Veterinary immunology and immunopathology, 59(3-4), 1997, pp. 311-322
As a cyclin-dependent kinases (Cdks) inhibitor (CDI), the protein p21(
WAF1/CIP1) is able to interfere with cell cycle progression. Its expre
ssion is upregulated by wild-type p53, and the p21(WAF1/CIP1) protein
appears to be a potent effector of the p53-dependent cell cycle regula
tory pathway. We have previously reported that p53 mutations frequentl
y occur during bovine leukemia virus (BLV)-induced leukemogenesis in c
attle but not in sheep. Therefore, we have investigated the involvemen
t of p21(WAF1/CIP1) mutations in the tumorigenic process associated wi
th BLV. We first cloned the bovine and ovine WAF1 genes and determined
the complete nucleotide sequences of their second coding exons. These
sequences share respectively 79% and 80% homology with those of the h
uman counterpart exon. In order to screen for mutations that could be
associated with BLV-induced pathogenicity, we performed single strand
conformation polymorphism (SSCP) assays on the WAF1 genes from BLV-ind
uced tumors. No WAF1 mutations were detected in any of the ten BLV-ind
uced bovine tumor samples. Among eleven sheep tumors and three ovine c
ell lines, only one sample revealed a single mutation in the WAF1 codi
ng sequence, but this mutation was silent at the translational level.
We concluded that mutations of the WAF1 gene are not involved in the d
evelopment of the tumors during BLV-induced leukemogenesis. (C) 1997 E
lsevier Science B.V.